Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cathepsin L is essential for onset of autoimmune diabetes in NOD mice
René Maehr, … , Christophe Benoist, Hidde L. Ploegh
René Maehr, … , Christophe Benoist, Hidde L. Ploegh
Published October 3, 2005
Citation Information: J Clin Invest. 2005;115(10):2934-2943. https://doi.org/10.1172/JCI25485.
View: Text | PDF
Research Article Immunology

Cathepsin L is essential for onset of autoimmune diabetes in NOD mice

  • Text
  • PDF
Abstract

Lysosomal proteases generate peptides presented by class II MHC molecules to CD4+ T cells. To determine whether specific lysosomal proteases might influence the outcome of a CD4+ T cell–dependent autoimmune response, we generated mice that lack cathepsin L (Cat L) on the autoimmune diabetes-prone NOD inbred background. The absence of Cat L affords strong protection from disease at the stage of pancreatic infiltration. The numbers of I-Ag7–restricted CD4+ T cells are diminished in Cat L–deficient mice, although a potentially diabetogenic T cell repertoire persists. Within the CD4+ T cell compartments of Cat L–deficient mice, there is an increased proportion of regulatory T cells compared with that in Cat L–sufficient littermates. We suggest that it is this displaced balance of regulatory versus aggressive CD4+ T cells that protects Cat L–deficient mice from autoimmune disease. Our results identify Cat L as an enzyme whose activity is essential for the development of type I diabetes in the NOD mouse.

Authors

René Maehr, Justine D. Mintern, Ann E. Herman, Ana-Maria Lennon-Duménil, Diane Mathis, Christophe Benoist, Hidde L. Ploegh

×

Figure 3

Options: View larger image (or click on image) Download as PowerPoint
Antigen presentation proceeds normally in Cat L–deficient mice. (A) CFSE...
Antigen presentation proceeds normally in Cat L–deficient mice. (A) CFSE-labeled BDC2.5 splenocytes were transferred into wild-type, Cat L–heterozygous, or Cat L–deficient mice. T cell proliferation was assessed 65 hours later by CFSE dilution in the CD4+ T cell population. The percentage of CD4+ T cells that exhibited dilution of CFSE as a result of cell division was determined for cells falling into the region of CFSE-positive cells that underwent at least 1 cell division (indicated by the bar). IngLN, inguinal lymph node; PanLN, pancreatic lymph node. (B) Results of 3 or more independent CFSE transfer experiments are summarized for wild-type (n = 5), Cat L–heterozygous (n = 4), and Cat L–deficient (n = 8) recipients; each point represents an individual mouse. (C) A total of 5 × 105 BDC2.5/NOD donor splenocytes were injected i.p. into Cat L–deficient NOD/Scid mice (n = 4) or wild-type controls (n = 5). Diabetes incidence was determined by urine glucose levels. (D) Splenocytes from recently diabetic mice were injected into sublethally irradiated Cat L–deficient NOD mice or wild-type and heterozygous controls. Insulitis was determined on histological nonconsecutive sections. The number of mice used in the experiments is indicated.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts